Stopping and Eradicating HIV
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-11078857
This research aims to find new ways to completely get rid of HIV from the body, even when patients are on long-term medication.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11078857 on ClinicalTrials.gov |
What this research studies
Even with effective HIV medications, the virus can hide in certain cells, making it hard to cure. This project explores why HIV persists and how the body's immune system, specifically CD8+ T cells and NK cells, might be strengthened to fight it off. We are also looking into how to prevent the virus from silencing these important immune cells. The goal is to develop new treatments that could lead to a cure for HIV.
Who could benefit from this research
Good fit: This foundational research is for patients living with HIV who are interested in understanding the future of cure strategies.
Not a fit: Patients not living with HIV would not directly benefit from this specific research focus.
Why it matters
Potential benefit: If successful, this work could lead to new therapies that eliminate HIV from the body, potentially freeing patients from lifelong medication.
How similar studies have performed: This project explores novel mechanisms and therapeutic strategies, building on existing knowledge but pushing into new, untested approaches for an HIV cure.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PAIARDINI, MIRKO — EMORY UNIVERSITY
- Study coordinator: PAIARDINI, MIRKO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus